We're sorry but this page doesn't work properly without JavaScript enabled. Please enable it to continue.
Feedback

Tear-film breakup: the role of membrane-associated mucin polymers

Formal Metadata

Title
Tear-film breakup: the role of membrane-associated mucin polymers
Title of Series
Number of Parts
22
Author
Contributors
License
CC Attribution - NonCommercial - NoDerivatives 4.0 International:
You are free to use, copy, distribute and transmit the work or content in unchanged form for any legal and non-commercial purpose as long as the work is attributed to the author in the manner specified by the author or licensor.
Identifiers
Publisher
Release Date
Language

Content Metadata

Subject Area
Genre
Abstract
The tear film has a heterogeneous structure. Next to the ocular surface is a region hundreds of nanometers thick that is rich in mucin polymers. Atop this so-called mucus layer lies the aqueous layer, which is up to 5 microns thick. The outer surface of the aqueous layer is covered by a thin lipid layer that is exposed to the ambient air. The mucin protects the ocular epithelium against pathogens, and clinical evidence points to progressive destruction of the membrane-associated mucins (MAM) in eye infection. From a fluid mechanical viewpoint, the MAM modifies the wetting condition on the solid substrate, and modulates the van der Waals forces between the interfaces. We hypothesize that a change in the configuration of the MAM, say from complete coverage to partial coverage, induces a stronger van der Waals attraction and enhances slip on the ocular surface. Both factors should accelerate the breakup of the tear film. This will explain clinical observations of faster tear-film breakup in various eye diseases. We numerically simulate the tear-film breakup process to study the effect of the MAM through an elevated Hamaker constant and a modified slip length. Results show that the loss of MAM indeed precipitates tear-film breakup, and suggest that the tear-film breakup time can be a potential diagnostic of eye diseases.